We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+18.96%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.25%
AUM
$658M
AUM Growth
+$76.7M
Cap. Flow
+$10.1M
Cap. Flow %
1.53%
Top 10 Hldgs %
30.63%
Holding
224
New
12
Increased
81
Reduced
70
Closed
6

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.41M
2
TMO icon
Thermo Fisher Scientific
TMO
+$1.95M
3
XYL icon
Xylem
XYL
+$1.52M
4
UNP icon
Union Pacific
UNP
+$821K
5
BA icon
Boeing
BA
+$783K

Top Sells

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$1.23M
2
CTRA
Coterra Energy
CTRA
+$991K
3
QCOM icon
Qualcomm
QCOM
+$892K
4
NTR icon
Nutrien
NTR
+$888K
5
HON icon
Honeywell
HON
+$611K

Sector Composition

Rank Sector Weight
1 Technology 23.12%
2 Industrials 19.12%
3 Miscellaneous 15.81%
4 Healthcare 13.07%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
51
McCormick & Company Non-Voting
MKC
$14B
$3.62M 0.55%
71,740
-3,955
-5% -$194K
GOOGL icon
52
Alphabet (Google) Class A
GOOGL
$4.14T
$3.41M 0.52%
9,555
+57
+0.6% +$20.5K
NVO
53
Novo Nordisk
NVO
$206B
$3.36M 0.51%
70,145
-219
-0.3% -$9.41K
IVV icon
54
iShares Core S&P 500 ETF
IVV
$889B
$3.32M 0.5%
4,430
-19
-0.4% -$13.8K
RTX icon
55
RTX Corp
RTX
$271B
$3.17M 0.48%
16,704
-10
-0.1% -$1.83K
PNC icon
56
PNC Financial Services
PNC
$98B
$3.05M 0.46%
12,370
+35
+0.3% +$7.84K
MMM icon
57
3M
MMM
$86.9B
$2.97M 0.45%
18,333
-20
-0.1% -$3.03K
GEHC icon
58
GE HealthCare
GEHC
$31.1B
$2.94M 0.45%
45,907
BCD icon
59
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$441M
$2.92M 0.44%
85,537
+14,826
+21% +$540K
FDX icon
60
FedEx
FDX
$76.3B
$2.87M 0.44%
9,161
+1
+0% +$363
VLO icon
61
Valero Energy
VLO
$107B
$2.74M 0.42%
10,518
-62
-0.6% -$15.3K
AXP icon
62
American Express
AXP
$220B
$2.64M 0.4%
7,791
+1
+0% +$320
FLR icon
63
Fluor
FLR
$7.51B
$2.61M 0.4%
49,835
-362
-0.7% -$17.7K
PG icon
64
Procter & Gamble
PG
$340B
$2.6M 0.39%
17,700
+2
+0% +$291
TMO icon
65
Thermo Fisher Scientific
TMO
$227B
$2.55M 0.39%
5,085
+4,055
+394% +$1.95M
KEYS icon
66
Keysight
KEYS
$55.7B
$2.49M 0.38%
7,113
KR icon
67
Kroger
KR
$35.9B
$2.47M 0.38%
44,557
BRKR icon
68
Bruker
BRKR
$8.91B
$2.45M 0.37%
40,750
SPXC icon
69
SPX Corp
SPXC
$9.84B
$2.45M 0.37%
10,000
MPC icon
70
Marathon Petroleum
MPC
$109B
$2.38M 0.36%
9,300
-1,000
-10% -$246K
BMY icon
71
Bristol-Myers Squibb
BMY
$136B
$2.35M 0.36%
40,778
-80
-0.2% -$4.59K
INTC icon
72
Intel
INTC
$506B
$2.35M 0.36%
16,811
FLS icon
73
Flowserve
FLS
$9.74B
$2.34M 0.36%
31,505
NXPI icon
74
NXP Semiconductors
NXPI
$57.5B
$2.33M 0.35%
8,280
+100
+1% +$27.6K
ABBV icon
75
AbbVie
ABBV
$453B
$2.31M 0.35%
9,174
-43
-0.5% -$9.25K

Similar funds

Mengis Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Mengis Capital Management held 224 positions worth $658M, up 13% from $581M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Mengis Capital Management's Q2 2026 filing shows 12 new, 81 increased, 70 reduced and 6 closed positions. Its largest new stake was Xylem: 13,188 shares worth $1.56M. The largest sale was Quanta Services, an estimated $1.23M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Industrials and Miscellaneous.

  • Mengis Capital Management's largest Q2 2026 buy was Xylem: 13,188 shares worth $1.56M.
  • Mengis Capital Management added most to Microsoft in Q2 2026, an estimated $2.41M increase.
  • Mengis Capital Management's biggest Q2 2026 reduction was Quanta Services, cutting an estimated $1.23M.
  • Mengis Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $991K.
  • Mengis Capital Management's ten largest holdings make up 31% of its $658M portfolio in Q2 2026.
  • Mengis Capital Management opened 12 new positions and closed 6 in Q2 2026.
  • Mengis Capital Management's portfolio value rose 13% quarter-over-quarter to $658M.

Based on Mengis Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.